Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis

Cancer Research

Volumn 59, Issue 10, 1999, Pages 2457-2463

  Ruiter, Gerald A ^a,b   Zerp, Shuraila F ^a,b   Bartelink, Harry ^a   Van Blitterswijk, Wim J ^b   Verheij, Marcel ^a,b  

^a Antoni van Leeuwenhoek Ziekenh/T ^*  (Netherlands)

^b Division of Cellular Biochemistry   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLLYSOPHOSPHOLIPID; EDELFOSINE; MILTEFOSINE; OCTADECYL (1,1 DIMETHYLPIPERIDINIO 4 YL)PHOSPHATE; PERIFOSINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL;

APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; ENDOTHELIUM, VASCULAR; GAMMA RAYS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 12; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPID ETHERS; PHOSPHORYLCHOLINE; PROTEIN KINASES; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 0033563010     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Unger, C., Sindermann, H., Peukert, M., Hilgard, P., Engel, J., and Eibl, H. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Prog. Exp. Tumor Res., 34: 153-159, 1992.
2. Ten Bokkel Huinink, W. W., Schornagel, J. H., Hilton, A., Somers, R., and Bartelink, H. Topical application of miltefosine against skin metastases of breast cancer. Proc. Am. Soc. Clin. Oncol. Annu. Meet., 11: 53, 1992.
3. Dummer, R., Roger, J., Vogt, T., Becker, J., Hefner, H., Sindermann, H., and Burg, G. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. Prog. Exp. Tumor Res., 34: 150-169, 1992.
4. Van Blitterswijk, W. J., Hilkmann, H., and Storme, G. A. Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion. Lipids, 22: 820-823, 1987.
5. Powis, G. Anticancer drugs acting against signaling pathways. Curr. Opin. Oncol., 7: 554-559, 1995.
6. Zhou, X., Lu, X., Richard, C., Xiong, W., Litchfield, D. W., Bittman, R., and Arthur, G. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells. J. Clin. Invest., 98: 937-944, 1996.
7. Zhou, X., and Arthur, G. Effect of 1-O-octadecyl-2-O-methyl-glycerophosphocholine on phosphatidylcholine and phosphatidylethanolamine synthesis in MCF-7 and A549 cells and its relationship to inhibition of cell proliferation. Eur. J. Biochem., 232: 881-888, 1995.
8. Wieder, T., Geilen, C. C., and Reutter, W. Antagonism of phorbol-ester-stimulated phosphatidylcholine biosynthesis by the phospholipid analogue hexadecylphosphocholine. Biochem. J., 291: 561-567, 1993.
9. Boggs, K. P., Rock, C. O., and Jackowski, S. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-racglycero-3-phosphocholine. J. Biol. Chem., 270: 11612-11618, 1995.
10. Maly, K., Uberall, F., Schubert, C., Kindler, E., Stekar, J., Brachwitz, H., and Grunicke, H. H. Interference of new alkylphospholipid analogues with mitogenic signal transduction. Anticancer Drug Des., 10: 411-425, 1995.
11. 3 and related analogs. A target for cancer chemotherapy. Adv. Exp. Med. Biol., 416: 173-180, 1996.
12. Zheng, B., Oishi, K., Shoji, M., Eibl, H., Berdel, W. E., Hajdu, J., Vogler, W. R., and Kuo, J. F. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues. Cancer Res., 50: 3025-3031, 1990.
13. Überall, F., Oberhuber, H., Maly, K., Zaknun, J., Demuth, L., and Grunicke, H. H. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res., 51: 807-812, 1991.
14. Berkovic, D., Berkovic, K., Fleer, E. A. M., Eibl, H., and Unger, C. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines. Eur. J. Cancer, 30: 509-515, 1994.
15. 3. Biochem. Biophys. Res. Commun., 192: 603-609, 1993.
16. 3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Cancer Res., 57: 1320-1328, 1997.
17. Diomede, L., Colotta, F., Piovani, B., Re, F., Modest, E. J., and Salmona, M. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int. J. Cancer, 53: 124-130, 1993.
18. Wieder, T., Orfanos, C. E., and Geilen, C. C. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine. J. Biol. Chem., 273: 11025-11031, 1998.
19. Berkovic, D., Grundel, O., Berkovic, K., Wildfang, I., Hess, C. F., and Schmoll, H. J. Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human carcinoma cells. Radiother. Oncol., 43: 293-301, 1997.
20. Chen, Y. R., Wang, X., Templeton, D., Davis, R. J., and Tan, T. H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem., 271: 31929-31936, 1996.
21. Dewey, W. C., Ling, C. C., and Meyn, R. E. Radiation-induced apoptosis: relevance to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 33: 781-796, 1995.
22. Haimovitz-Friedman, A., Balaban, N., McLoughlin, M., Ehleiter, D., Michaeli, J., Vlodavsky, I., and Fuks, Z. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res., 54: 2591-2597, 1994.
23. Quintans, J., Kilkus, J., McShan, C. L., Gottschalk, A. R., and Dawson, G. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem. Biophys. Res. Commun., 202: 710-714, 1994.
24. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (Lond.), 380: 75-79, 1996.
25. Chauhan, D., Kharbanda, S., Ogata, A., Urashima, M., Teoh, G., Robertson, M., Kufe, D. W., and Anderson, K. C. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood, 89: 227-234, 1997.
26. Chen, Y. R., Meyer, C. F., and Tan, T. H. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in γ radiation-induced apoptosis. J. Biol. Chem., 271: 631-634, 1996.
27. Wilson, D. J., Fortner, K. A., Lynch, D. H., Mattingly, R. R., Macara, I. G., Posada, J. A., and Budd, R. C. JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol., 26: 989-994, 1996.
28. Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M., and Rubin, L. L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron, 14: 927-939, 1995.
29. Frisch, S. M., Vuori, K., Kelaita, D., and Sicks, S. A role for Jun-N-terminal kinase in anoikis; suppression by bc1-2 and crmA. J. Cell Biol., 135: 1377-1382, 1996.
30. Goillot, E., Raingeaud, J., Ranger, A., Tepper, R. I., Davis, R. J., Harlow, E., and Sanchez, I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA, 94: 3302-3307, 1997.
31. Zanke, B. W., Boudreau, K., Rubie, E., Winnett, E., Tibbies, L. A., Zon, L., Kyriakis, I., Liu, F. F., and Woodgett, J. R. The stress-activated protein kinase pathway mediates cell death following injury induced by cisplatinum, UV irradiation or heat. Curr. Biol., 6: 606-613, 1996.
32. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Washington DC), 270: 1326-1331, 1995.
33. Cosulich, S., and Clarke, P. Apoptosis: does stress kill? Curr. Biol., 6: 1586-1588, 1996.
34. Canman, C. E., and Kastan, M. B. Signal transduction. Three paths to stress. Nature (Lond.), 384: 213-214, 1996.
35. Mollinedo, F., Gajate, C., and Modolell, M. The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells. Biochem. J., 302: 325-329, 1994.
36. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA, 89: 5408-5412, 1992.
37. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
38. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond.), 169: 156-160, 1994.
39. Laska, E. M., Meisner, M., and Tang, D-I. Classification of the effectiveness of combination treatments. Stat. Med., 16: 2211-2228, 1997.
40. Machado, S. G. A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments. Stat. Med., 13: 2289-2309, 1994.
41. Verheij, M., Ruiter, G. A., Zerp, S. F., van Blitterswijk, W. J., Fuks, Z., Haimovitz-Friedman, A., and Bartelink, H. The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis. Radiother. Oncol., 47: 225-232, 1998.
42. Brown, P. H., Alani, R., Preis, L. H., Szabo, E., and Birrer, M. J. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene, 8: 877-886, 1993.
43. Vogler, W. R., and Berdel, W. E. Autologous bone marrow transplantation with alkyl-lysophospholipid-purged marrow. J. Hematother., 2: 93-102, 1993.
44. Wang, T. H., Wang, H. S., Ichijo, H., Giannakakou, P., Foster, J. S., Fojo, T., and Wimalasena, J. Microtubule-interfering agents activate c-Jun N-terminal kinase/ stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem., 273: 4928-4936, 1998.
45. Sanchez-Perez, I., Murguia, J. R., and Perona, R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene, 16: 533-540, 1998.
46. Dérijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Han, J., Ulevitch, R. J., and Davis, R. J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science (Washington DC), 267: 682-685, 1995.
47. Lin, A., Minden, A., Martinetto, H., Claret, F. X., Lange-Carter, C., Mercurio, F., Johnson, G. L., and Karin, M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science (Washington DC). 268: 286-290, 1995.
48. Sanchez, I., Hughes, R. T., Mayer, B. J., Yee, K., Woodgett, J. R., Avruch, J., Kyriakis, J. M., and Zon, L. I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (Lond.), 372: 794-798, 1994.
49. Yan, M., Dai, T., Deak, J. C., Kyriakis, J. M., Zon, L. I., Woodgett, J. R., and Templeton, D. J. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature (Lond.), 372: 798-800, 1994.
50. Davis, R. J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem., 268: 14553-14556, 1993.
51. Minden, A., Lin, A., Smeal, T., Dérijard, B., Cobb, M., Davis, R., and Karin, M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol., 14: 6683-6688, 1994.
52. Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E., and Woodgett, J. R. Phosphorylation of c-jun mediated by MAP kinases. Nature (Lond.), 353: 670-674, 1991.
53. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., and Spiegel, S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature (Lond.), 381: 800-803, 1996.
54. Jarvis, W. D., Fornari, F. A., Jr., Auer, K. L., Freemerman, A. J., Szabo, E., Birrer, M. J., Johnson, C. R., Barbour, S. E., Dent, P., and Grant, S. Coordinate regulation of stress-and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol. Pharmacol., 52: 935-947, 1997.
55. Wang, X., Martindale, J. L., Liu, Y., and Holbrook, N. J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J., 333: 291-300, 1998.
56. Fuks, Z., Persaud, R. S., Alfieri, A., McLoughlin, M., Ehleiter, D., Schwatz, J. L., Seddon, A. P., Cordon-Cardo, C., and Haimovitz-Friedman, A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res., 54: 2582-2590, 1994.
57. Chmura, S. J., Mauceri, H. J., Advani, S., Heimann, R., Becket, M. A., Nodzenski, E., Quintans, J., Kufe, D. W., and Weichselbaum, R. R. Decreasing the apoptotic threshold of tumor cells through protein kinase C: inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res., 57: 4340-4347, 1997.
58. Carter, S., Auer, K. L., Reardon, D. B., Birrer, M., Fisherm, P. B., Valerie, K., Schmidt-Ullrich, R. S., Mikkelsen, R., and Dent, P. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene, 16: 2787-2796, 1998.
59. Hartfield, P. J., Mayne, G. C., and Murray, A. W. Ceramide induces apoptosis in PC12 cells. FEBS Lett., 401: 148-152, 1997.
60. Jarvis, W. D., Kolesnick, R. N., Fomari, F. A., Traylor, R. S., Gewirtz, D. A., and Grant, S. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA, 91: 73-77, 1994.
61. Karasavvas, N., Erukulla, R. K., Bittman, R., Lockshin, R., and Zakeri, Z. Stereospecific induction of apoptosis in U937 cells by N-octanoyl-sphingosine stereoisomers and N-octyl-sphingosine. Eur. J. Biochem., 236, 729-737, 1996.
62. Tepper, A. D., Boesen-de Cock, J. G. R., de Vries, E., Borst, J., and van Blitterswijk, W. J. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition. J. Biol. Chem., 272: 24308-24312, 1997.
63. Huang, C., Ma, W., Ding, M., Bowden, G. T., and Dong, Z. Direct evidence for an important role of sphingomyelinase in ultraviolet-induced activation of c-Jun N-terminal kinase. J. Biol. Chem., 272: 27753-27757, 1997.
64. Jarvis, W. D., Fornari, F. A., Jr., Traylor, R. S., Martin, H. A., Kramer, L. B., Erukulla, R. K., Bittman, R., and Grant, S. J. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem., 271: 8275-8284, 1996.